HONG KONG -- Stocks of major Chinese pharmaceutical companies tumbled Thursday due to concerns that the U.S. is considering major restrictions on the sector, which has taken off in recent years.
Trump reportedly considering new curbs on imports of experimental pharmaceuticals
The U.S. is threatening China's pharmaceuticals boom with possible import restrictions and policies to promote domestic production. © Reuters
HONG KONG -- Stocks of major Chinese pharmaceutical companies tumbled Thursday due to concerns that the U.S. is considering major restrictions on the sector, which has taken off in recent years.